FDA-approvedFDAADAObesitytirzepatideliraglutide
…pproved dose of the medication.¶These are medications currently FDA-approved for the treatment of the identified obesity-related disease or …
8articles mentioning funders
9funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: FDA-approved ×
FDA-approved
This funder is selected. Its supporting articles are shown below.
Articles mentioning FDA-approved
8 articles · page 1 of 1FDA-approvedTenecteplaseAlteplaseTNKtPAAIS
…ered within 4.5 hours of stroke symptoms. Tenecteplase (TNK) is FDA-approved for STEMI, but its off-label use for AIS is rising due to its g…
European Medicines AuthorityEuropean Medicines AgencyFDA-approvedMinistry of HealthFDAosimertinibdurvalumabpembrolizumabalectinib
…FDA-approved for patients with over 1% PD-1 expression, but the European Medicines Authority limited its approval to those with over 50% PD-1 expression.4De…
FDAU.S. Food and Drug AdministrationFDA-approveddonanemabAducanumablecanemabAlzheimer’s diseaseADMCImild cognitive impairment+2 more
…ts have been approved by the U.S. Food and Drug Administration (FDA) for mild cognitive impairment (MCI) or mild dementia due to Al…
Food and Drug AdministrationFDA-approvedAChEIAlzheimer’s diseaseADmABsmAB
…jective This study aimed to evaluate the cumulative benefits of Food and Drug Administration (FDA)-approved monoclonal antibodies (mABs), administered at FD…
FDA-approvedFood and Drug Administrationadvanced melanomabromocriptinemetoclopramideMCPBRCCollaborative Cross mice
…is receptor as a target to improve ICI outcomes.Methods We used FDA-approved D2R agonist bromocriptine (BRC) and D2R antagonist metocloprami…
FDA-approvedFDAAVO-100B cell malignanciesRaji lymphomaB cell lymphomaAAVCAR-T cell therapies
…afe, off-the-shelf treatment option that is currently used in 7 FDA-approved gene therapies. AVO-100 is a gene therapy that uses AAV with ca…
US Food and Drug AdministrationFDA-approvedH1Acancer typesH1A-inducedImmune checkpoint therapies
…s in the treatment of patients of varying cancer types. Current US Food and Drug Administration (FDA)-approved therapies function to prevent PD-1 binding to PD…